Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease
Supplementary Data
- Supplementary Figure 1 - CABLES1 immunostaining in non-tumoral pituitary tissue. Representative images of non-tumoral tissue surrounding pituitary adenomas, a) Patient 3, b) Patient 4. Magnification: 20X (PDF 3762 KB)
- Supplementary Table 1 - Primers for PCR and Sanger sequencing of CABLES1 (PDF 14 KB)
- Supplementary Table 2 - CABLES1 variants identified in pediatric Cushing’s disease patients (PDF 140 KB)
This Article
-
Endocr Relat Cancer August 1, 2017 vol. 24 no. 8 379-392
- Free via Open Access: OA
- OA Abstract
- OA Figures Only
- OA Full Text
- OA Full Text (PDF)
- Supplementary Data
Most
-
Viewed
- Association of Hashimoto's thyroiditis with thyroid cancer
- Progesterone metabolites in breast cancer
- The emerging roles of DNA methylation in the clinical management of prostate cancer
- Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
- EGF mutant receptor vIII as a molecular target in cancer therapy
-
Cited
- Fibroblast growth factors, their receptors and signaling
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
- BRAF mutation in thyroid cancer
- Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
- mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
